Statistics
Publications
1
Citations
14
H-Index
1
Active since
2018
Affiliations
Korea Pharma (South Korea)(Current)
Doyoung Lee is an author at Korea Pharma (South Korea) specializing in metabolic reprogramming, impaired insulin sensitivity, and blood glucose regulation.
Publications per year
2018–2018
1
1
An MG53-IRS1-interaction disruptor ameliorates insulin resistance
Jun Sub Park, Hyun Lee, Bo Woon Choi et al. · Experimental & Molecular Medicine · 2018 · 14 citations · Full text
1–1 of 1